Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Nu-Med Plus (NUMD) Equity Ratio (2016 - 2021)

Nu-Med Plus' Equity Ratio history spans 10 years, with the latest figure at 1.37 for Q3 2021.

  • Quarterly results put Equity Ratio at 1.37 for Q3 2021, down 500.43% from a year ago — trailing twelve months through Sep 2021 was 1.37 (down 500.43% YoY), and the annual figure for FY2020 was 0.84, up 110.37%.
  • Equity Ratio for Q3 2021 was 1.37 at Nu-Med Plus, down from 0.02 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.84 in Q4 2020 to a low of 8.09 in Q4 2019.
  • The 5-year median for Equity Ratio is 0.06 (2018), against an average of 1.35.
  • The sharpest move saw Equity Ratio soared 259.6% in 2018, then crashed 7793.8% in 2019.
  • Year by year, Equity Ratio stood at 0.17 in 2017, then tumbled by 31.63% to 0.11 in 2018, then tumbled by 7153.68% to 8.09 in 2019, then soared by 110.37% to 0.84 in 2020, then plummeted by 262.79% to 1.37 in 2021.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 1.37, 0.02, and 0.67 for Q3 2021, Q2 2021, and Q1 2021 respectively.